How estrogen affects brain regions that control motivation and dopamine
Official title: Estrogen modulation of the lateral habenula and its ability to inhibit midbrain dopamine neurons
Funded at University of Maryland Baltimore · NIH-10766255 · Data updated 2026-11-12
This study is looking at how estrogen affects a part of the brain that helps control motivation and behavior, especially in relation to mental health issues like depression and addiction, to find better treatment options that take into account differences between men and women.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | January 20, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $193,125 |
| NIH project number | 5R21MH129809-02 |
| Project ID | NIH-10766255 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing mental health disorders, particularly those with conditions like depression or addiction, who may be affected by hormonal changes.
✕Less likely to help
Patients who do not have hormonal influences on their mental health conditions or those with unrelated psychiatric disorders may not benefit from this research.
What this research studies
This research investigates the role of estrogen in modulating the lateral habenula, a brain region that influences dopamine neuron activity, which is crucial for motivation and behavior. The study focuses on understanding how sex differences and hormonal changes impact mental health disorders such as depression and addiction. By examining these mechanisms in animal models, the research aims to uncover potential treatment strategies that consider hormonal influences on brain function. Patients may benefit from insights that lead to more effective, sex-specific therapies for mental health conditions.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for mental health disorders that take into account hormonal influences, potentially enhancing patient outcomes.
How similar studies have gone: Previous research has indicated that hormonal modulation of brain function can significantly impact mental health outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Brown, Paul Leon — University of Maryland Baltimore
- Study coordinator: Brown, Paul Leon
Related research
Other NIH-funded projects on the same topics.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
NPRL2 loss and focal cortical dysplasia in epilepsy
This grant investigates how losing NPRL2 in the brain contributes to focal cortical dysplasia and epilepsy in children.
-
New way to make head and neck cancer treatments work better
A research project at the University of Maryland Baltimore aims to improve treatment for advanced head and neck cancer, with a focus on making cisplatin and newer therapies work better while reducing kidney side effects.
-
Genetics and function of inherited brain disorders that affect thinking and behavior
Scientists are studying how genes and cellular helpers shape brain development and why certain kids have intellectual disabilities and adaptive-behavior challenges.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.